Analyst Ratings for Jazz Pharmaceuticals (JAZZ)

JAZZ Rating Summary

JAZZ Price Target Summary

  |   Expand Research on JAZZ
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $68.50 (-1.7%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
5/31/2013 Stifel Nicolaus New Coverage Buy
(N/A)
80.00
(N/A)
68.44 69.66 1.78% Details
3/28/2013 JMP Securities New Coverage Market Outperform
(N/A)
66.00
(N/A)
56.42 69.66 23.47% Details
3/11/2013 Cantor Fitzgerald
» Updated 5/31/2013
New Coverage Buy
(N/A)
86.00
(N/A)
58.50 69.66 19.08% Details
11/29/2012 UBS
» Updated 2/27/2013
New Coverage Buy
(N/A)
67.00
(64.00)
51.07 69.66 36.4% Details
11/27/2012 Citi New Coverage Buy
(N/A)
70.00
(N/A)
51.85 69.66 34.35% Details
9/27/2012 Brean Capital New Coverage Buy
(N/A)
81.00
(N/A)
54.79 69.66 27.14% Details
9/18/2012 Guggenheim
» Updated 5/22/2013
New Coverage Buy
(N/A)
69.00
(N/A)
55.29 69.66 25.99% Details
9/11/2012 Cowen Upgrade Outperform
(Neutral)
N/A
(N/A)
43.56 69.66 59.92% Details
8/27/2012 WallachBeth Capital New Coverage Buy
(N/A)
63.00
(N/A)
46.50 69.66 49.81% Details
6/21/2012 Barclays
» Updated 9/18/2012
New Coverage Overweight
(N/A)
60.00
(N/A)
46.03 69.66 51.34% Details
5/23/2012 Credit Suisse New Coverage Outperform
(N/A)
65.00
(N/A)
43.66 69.66 59.55% Details
5/23/2012 Oppenheimer
» Updated 9/28/2012
New Coverage Outperform
(N/A)
66.00
(66.00)
43.66 69.66 59.55% Details
4/13/2012 Leerink Swann
» Updated 9/11/2012
New Coverage Outperform
(N/A)
70.00
(N/A)
44.64 69.66 56.05% Details
12/8/2011 WBB Securities Downgrade Hold
(N/A)
40.00
(N/A)
38.96 69.66 78.8% Details
9/30/2011 Auriga
» Updated 5/9/2012
New Coverage Buy
(N/A)
64.00
(N/A)
41.68 69.66 67.13% Details
Like JAZZ Ratings? Also take a look at WCRX, QCOR

JAZZ Ratings News